American International Group, Inc. Halozyme Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$33.68 - $41.95 $138,930 - $173,043	-4,125 Reduced 1.71%	237,773 $9.67 Million
Q4 2023 Feb 13, 2024	SELL	$33.32 - $42.1 $255,297 - $322,570	-7,662 Reduced 3.07%	241,898 $8.94 Million
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $443,353 - $535,404	-12,160 Reduced 4.65%	249,560 $9.53 Million
Q2 2023 Aug 04, 2023	SELL	$30.28 - $38.74 $297,773 - $380,969	-9,834 Reduced 3.62%	261,720 $9.44 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $21,227 - $35,982	-646 Reduced 0.24%	271,554 $10.4 Million
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $328,892 - $488,002	-8,210 Reduced 2.93%	272,200 $15.5 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $369,387 - $496,414	-9,587 Reduced 3.31%	280,410 $11.1 Million
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $589,084 - $761,787	-15,772 Reduced 5.16%	289,997 $12.8 Million
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $140,316 - $180,212	-4,389 Reduced 1.42%	305,769 $12.2 Million
Q4 2021 Feb 11, 2022	SELL	$31.82 - $40.75 $335,000 - $429,016	-10,528 Reduced 3.28%	310,158 $12.5 Million
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $216,278 - $260,973	5,622 Added 1.78%	320,686 $13 Million
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $92,672 - $122,425	2,386 Added 0.76%	315,064 $14.3 Million
Q1 2021 May 07, 2021	BUY	$39.51 - $51.45 $25,839 - $33,648	654 Added 0.21%	312,678 $13 Million
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $5.96 Million - $10.1 Million	230,808 Added 284.19%	312,024 $13.3 Million
Q3 2020 Nov 04, 2020	SELL	$25.74 - $29.63 $47,516 - $54,696	-1,846 Reduced 2.22%	81,216 $2.13 Million
Q2 2020 Aug 12, 2020	BUY	$16.25 - $26.81 $56,062 - $92,494	3,450 Added 4.33%	83,062 $2.23 Million
Q1 2020 May 04, 2020	SELL	$13.9 - $21.83 $139,347 - $218,845	-10,025 Reduced 11.18%	79,612 $1.43 Million
Q4 2019 Feb 05, 2020	SELL	$14.93 - $19.53 $11,272 - $14,745	-755 Reduced 0.84%	89,637 $1.59 Million
Q3 2019 Nov 08, 2019	SELL	$15.2 - $17.69 $9,576 - $11,144	-630 Reduced 0.69%	90,392 $1.4 Million
Q2 2019 Aug 13, 2019	BUY	$14.75 - $17.26 $168,917 - $197,661	11,452 Added 14.39%	91,022 $1.56 Million
Q1 2019 May 06, 2019	SELL	$13.94 - $17.58 $35,951 - $45,338	-2,579 Reduced 3.14%	79,570 $1.28 Million
Q4 2018 Feb 13, 2019	SELL	$13.33 - $18.66 $8,424 - $11,793	-632 Reduced 0.76%	82,149 $1.2 Million
Q3 2018 Nov 09, 2018	BUY	$16.68 - $18.41 $24,886 - $27,467	1,492 Added 1.84%	82,781 $1.5 Million
Q2 2018 Aug 08, 2018	BUY	$16.87 - $20.3 $84,366 - $101,520	5,001 Added 6.56%	81,289 $1.37 Million
Q1 2018 May 07, 2018	SELL	$17.06 - $21.2 $69,963 - $86,941	-4,101 Reduced 5.1%	76,288 $1.49 Million
Q4 2017 Feb 09, 2018	BUY	$16.75 - $20.8 $19,748 - $24,523	1,179 Added 1.49%	80,389 $1.63 Million
Q3 2017 Nov 09, 2017	BUY	$11.76 - $17.4 $931,509 - $1.38 Million	79,210	79,210 $1.38 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account